Lead party: Enso Equity (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Ingress Healthcare
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity) · Deal amount: US$322,160
Investors/buyers: Enso Equity, Pegasus Capital Advisors
Legal advisers: not identified in the source record.
Source: announced 15 April 2020. Original announcement: ventureburn.com.


